A lead-optimization strategy combining porin permeation properties and biochemical potency leads to development of a new class of antibiotic based on broad inhibition of penicillin-binding proteins from Gram-negative bacteria.
- Thomas F. Durand-Reville
- Alita A. Miller
- Ruben A. Tommasi